Clinical status for Vacc-4x and Revlimid®

BioCentury Publications, Inc., a leading provider of value-added information on strategic issues in life science, has in their report BioCentury Week in Review Aug 29, 2011, published the clinical status of the upcoming clinical trial regarding Bionor’s therapeutic vaccine, Vacc-4x in combination with Revlimid®. Link to the reprint

The release as fetched from its publisher. bionorholding.com ↗